Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Response to oral forodesine in refractory cutaneous T-Cell lymphoma: Interim results of a phase I/II study Duvic, M., Forero-Torres, A., Foss, F., Olsen, E., Kim, Y. AMER SOC HEMATOLOGY. 2007: 44A
View details for Web of Science ID 000251100800123